Diabetic cardiomyopathy treatment shows promise in ARISE-HF
James Januzzi Jr., MD, said the treatment’s overall impact was neutral, but he and his team saw “a very clear and encouraging signal.”
James Januzzi Jr., MD, said the treatment’s overall impact was neutral, but he and his team saw “a very clear and encouraging signal.”
ACC President Cathie Biga, MSN, FACC launched her “Heart Talk with Cathie” presidential discussion live from MedAxiom’s CVTransforum in Atlanta. With the hel…
BackgroundAsian and multiracial individuals represent the 2 fastest growing racial and ethnic groups in the United States, yet most prior studies report Asian American and Native…
SCAI actively represents its members at the state and federal levels, maintaining regular contact with congressional leaders and key administration officials, tracking critical legislative matters…
A collaboration with the American Heart Association and Brigham and Women’s Hospital, the Apple Heart and Movement study will explore the links between physical activity…
In a first-in-human study, a new class of transcatheter heart valve demonstrated good safety and restored aortic blood flow to levels similar to a healthy…
Home News Large Registry Data Demonstrates PCI for Stable CAD Can Be Safely Performed Before, During, or After TAVR Long Beach, Calif. – New data…
Long Beach, Calif. – New clinical results highlight the need for inclusive approaches and comprehensive examinations of treatment options for peripheral artery disease (PAD), including…
Long Beach, Calif. – Recent findings from a study on a transcatheter heart valve (THV) system, which includes a new class of transcatheter aortic valve,…
Use of advanced thrombolysis in the U.S. remains low and is prone to disparate use among women and Black patients presenting with pulmonary embolism, a…
BACKGROUND: The morbidity and mortality rates of patients with heart failure (HF) and functional mitral regurgitation (MR) remain substantial despite guideline-directed medical therapy for HF.…